Sucharita Rao Palepu appointed as Granules India independent director

Published On 2021-12-24 07:52 GMT | Update On 2021-12-25 07:09 GMT

New Delhi: Drug maker, Granules india has recently announced the appointment of Mrs. Sucharita Rao Palepu as an Additional Director, categorized as Non-Executive Independent, on the Board of the Company with effect from December 22, 2021.

Sucharita Rao Palepu, aged 55 years, is a Chartered Accountant and has over 30 years of professional experience in Information Technology and Financial Services Industries. She is currently a Strategic Advisor specialising in Organization & HR Transformation initiatives, prior to which, she was Global Head- Human Resources at Tech Mahindra Ltd. Her areas of expertise include helping organizations boost their competitive advantage and performance.

Over her career, Sucharita was instrumental in initiating several significant transformation programs and large-scale HR interventions, with a proven track record of delivering successful change in a global, diverse, multi-cultural and complex environment. With a strong commercial orientation, she is known for bringing about pioneering changes across various initiatives.

Sucharita has been acknowledged as a thought leader and has very effectively led extremely complex organization integrations. She has introduced several next practices aligned to Organization Culture and the same have been recognised across various platforms as well.

She is actively involved in a few NGOs and is also a certified coach. She was awarded Exemplary Woman in Leader Award (Apac) in HR Branding Awards 2015-16 and Women Super Achievers Award in HR Branding Awards 2009-10.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Sucharita Rao Palepu appointed as Granules India independent director

Similar News

Biocon inaugurates first US manufacturing facility in New Jersey

CDSCO Criminal Prosecution Against IndiaMART Put on Hold by Delhi HC Till Sept 17

Novo Nordisk Gets CDSCO Panel Nod for Rybelsus Label Update, Aligned with EMA

NPPA Updates Ceiling Price Applicability for Ringer Lactate Non-Glass Packs, Details

CDSCO Eases Rules for Biopharma Research, Will Accept Lab Biosafety Committee Approvals

41 Pharmacies in Delhi Caught Illegally Selling Abortion Pills Mifepristone, Misoprostol

Visakhapatnam Pharma Plant Gas Leak Claims Chemist's Life, CITU Alleges Negligence

Torrent Pharma to acquire 26% stake in Torrent Urja 27 for captive renewable power project